Ranny Yaffe
Chief Executive Officer at VESSL Therapeutics Ltd.
Profile
Ranny Yaffe is currently the Co-Chief Executive Officer at VESSL Therapeutics Ltd.
He started this position in 2020.
Prior to his current role, Mr. Yaffe obtained an undergraduate degree and an MBA from Technion-Israel Institute of Technology.
Ranny Yaffe active positions
| Companies | Position | Start |
|---|---|---|
VESSL Therapeutics Ltd.
 VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Chief Executive Officer | 31/12/2019 |
Training of Ranny Yaffe
| Technion-Israel Institute of Technology | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
VESSL Therapeutics Ltd.
VESSL Therapeutics Ltd. Medical SpecialtiesHealth Technology VESSL Therapeutics Ltd. develops cell-based therapies for large patient populations. Its solutions include MultiGeneAngio fo Peripheral Artery Disease and MultiGeneGraft for end-stage renal disease. The company was founded in August 2000 by Moshe Y. Flugelman and Basil S. Lewis and is headquartered in Haifa, Israel. | Health Technology |
- Stock Market
- Insiders
- Ranny Yaffe
